|
|
General Cardiovascular Risk Profile for Use in
Primary Care: 8491 Patients In The
Framingham Heart Study
|
|
|
|
Risk Factors
|
Select
Pre-Treatment Values Here
|
Risk Points
|
Select
Post-Treatment Values Here*
|
Risk Points
|
|
|
|
Gender
|
|
|
|
|
|
|
|
Age (yrs)
|
|
|
|
|
|
|
|
Total Cholesterol in
mg%
|
|
|
|
|
|
|
|
HDL Cholesterol in
mg%
|
|
|
|
|
|
|
|
Systolic BP (if
patient receiving BP meds)
|
|
|
|
|
|
|
|
Systolic BP (if
patient not receiving BP meds)
|
|
|
|
|
|
|
|
Is Patient Currently Smoking?
|
|
|
|
|
|
|
|
Diabetes
|
|
|
|
|
|
|
|
Point Total
|
|
|
|
Benefits
of treatment in this calculator are speculative,
|
|
|
|
10-year
risk of developing coronary heart disease, stroke, peripheral artery disease
or heart failure in %
|
|
|
|
|
|
|
|
Patient's
Cardiovascular Age in Years. (Age of a pt with no CVD risk factors who has this many points.)
|
|
|
|
and
assume full reversibility of the effects of risk factors. - JC
|
|
|
|
D’Agostino RB; Vasan RS; Pencina MJ; Wolf PA;
Cobain M; Massaro JM; Kannel WB. General Cardiovascular Risk Profile for Use
in Primary Care. The Framingham Heart Study. Circulation. 2008;117:743-753.
|
|
|
|
Data Source:The Framingham
Heart Study (FHS). Period: 1967 onward. Risk categories: 0-6% Low, 6-20% Med,
greater than 20% High.
|
|
|
|
Comment: This study is the product of the Framingham
Heart Study, which has been ongoing since 1948. The data that was used
|
|
|
|
in the current calculator design was gathered from 3 cohorts
(1967-1971, 1971-1975 and 1984-1987). This included 4522 women
|
|
|
|
and 3969 men, none of whom had evidence of cardiovascular disease at
the time of entry into the study. The average age of these
|
|
|
|
subjects was 49 years (range 31 to 74 years)
and the patients were followed for 12 years. This gives a total group
experience
|
|
|
|
of about 100,000 patient-years of observation. Systolic blood pressure
was measured twice at each visit. Cigarette smoking was determined
|
|
|
|
by pt. report. Diabetes = fasting glucose
exceeding 126 or 140 mg%. BMI, trigylcerides, LDL, and diastolic BP did not
improve the model.
|
|
|
|
*Web calculator design and HTML transfer by Dr. John Coyle, 2008.
Post-treatment benefits are speculative, not proposed by FHS.
|
|